ASTH
Price
$22.78
Change
-$0.24 (-1.04%)
Updated
Dec 4, 04:59 PM (EDT)
Capitalization
1.15B
77 days until earnings call
Intraday BUY SELL Signals
HCA
Price
$487.57
Change
+$0.81 (+0.17%)
Updated
Dec 4, 04:59 PM (EDT)
Capitalization
111.08B
61 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

ASTH vs HCA

Header iconASTH vs HCA Comparison
Open Charts ASTH vs HCABanner chart's image
Astrana Health
Price$22.78
Change-$0.24 (-1.04%)
Volume$4.72K
Capitalization1.15B
HCA Healthcare
Price$487.57
Change+$0.81 (+0.17%)
Volume$11.76K
Capitalization111.08B
ASTH vs HCA Comparison Chart in %
ASTH
Daily Signal:
Gain/Loss:
HCA
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
ASTH vs. HCA commentary
Dec 05, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ASTH is a Hold and HCA is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Dec 05, 2025
Stock price -- (ASTH: $23.02 vs. HCA: $486.77)
Brand notoriety: ASTH and HCA are both not notable
Both companies represent the Hospital/Nursing Management industry
Current volume relative to the 65-day Moving Average: ASTH: 81% vs. HCA: 149%
Market capitalization -- ASTH: $1.15B vs. HCA: $111.08B
ASTH [@Hospital/Nursing Management] is valued at $1.15B. HCA’s [@Hospital/Nursing Management] market capitalization is $111.08B. The market cap for tickers in the [@Hospital/Nursing Management] industry ranges from $111.08B to $0. The average market capitalization across the [@Hospital/Nursing Management] industry is $4.3B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ASTH’s FA Score shows that 1 FA rating(s) are green whileHCA’s FA Score has 4 green FA rating(s).

  • ASTH’s FA Score: 1 green, 4 red.
  • HCA’s FA Score: 4 green, 1 red.
According to our system of comparison, HCA is a better buy in the long-term than ASTH.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ASTH’s TA Score shows that 5 TA indicator(s) are bullish while HCA’s TA Score has 3 bullish TA indicator(s).

  • ASTH’s TA Score: 5 bullish, 6 bearish.
  • HCA’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, both ASTH and HCA are a bad buy in the short-term.

Price Growth

ASTH (@Hospital/Nursing Management) experienced а -0.13% price change this week, while HCA (@Hospital/Nursing Management) price change was -5.44% for the same time period.

The average weekly price growth across all stocks in the @Hospital/Nursing Management industry was +0.40%. For the same industry, the average monthly price growth was -1.77%, and the average quarterly price growth was +1.75%.

Reported Earning Dates

ASTH is expected to report earnings on Feb 19, 2026.

HCA is expected to report earnings on Feb 03, 2026.

Industries' Descriptions

@Hospital/Nursing Management (+0.40% weekly)

Hospital/Nursing Management companies own and operate health care facilities. Their operations include nursing homes, acute care facilities, retirement centers and outpatient surgery centers. HCA Healthcare Inc., Alcon Inc. and Universal Health Services, Inc. are some major companies in this industry. Technology has been at the forefront of development of advanced solutions, including quicker diagnoses of complex conditions. Investments in new diagnostics, healthcare IoT, and other healthcare technologies continue to gather momentum in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
HCA($111B) has a higher market cap than ASTH($1.16B). ASTH has higher P/E ratio than HCA: ASTH (121.16) vs HCA (18.82). HCA YTD gains are higher at: 63.149 vs. ASTH (-26.990). HCA has higher annual earnings (EBITDA): 14.4B vs. ASTH (112M). ASTH has less debt than HCA: ASTH (448M) vs HCA (46.4B). HCA has higher revenues than ASTH: HCA (72.7B) vs ASTH (2.42B).
ASTHHCAASTH / HCA
Capitalization1.16B111B1%
EBITDA112M14.4B1%
Gain YTD-26.99063.149-43%
P/E Ratio121.1618.82644%
Revenue2.42B72.7B3%
Total Cash342MN/A-
Total Debt448M46.4B1%
FUNDAMENTALS RATINGS
ASTH vs HCA: Fundamental Ratings
ASTH
HCA
OUTLOOK RATING
1..100
7278
VALUATION
overvalued / fair valued / undervalued
1..100
84
Overvalued
18
Undervalued
PROFIT vs RISK RATING
1..100
9410
SMR RATING
1..100
8742
PRICE GROWTH RATING
1..100
889
P/E GROWTH RATING
1..100
419
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

HCA's Valuation (18) in the Hospital Or Nursing Management industry is significantly better than the same rating for ASTH (84) in the null industry. This means that HCA’s stock grew significantly faster than ASTH’s over the last 12 months.

HCA's Profit vs Risk Rating (10) in the Hospital Or Nursing Management industry is significantly better than the same rating for ASTH (94) in the null industry. This means that HCA’s stock grew significantly faster than ASTH’s over the last 12 months.

HCA's SMR Rating (42) in the Hospital Or Nursing Management industry is somewhat better than the same rating for ASTH (87) in the null industry. This means that HCA’s stock grew somewhat faster than ASTH’s over the last 12 months.

HCA's Price Growth Rating (9) in the Hospital Or Nursing Management industry is significantly better than the same rating for ASTH (88) in the null industry. This means that HCA’s stock grew significantly faster than ASTH’s over the last 12 months.

ASTH's P/E Growth Rating (4) in the null industry is in the same range as HCA (19) in the Hospital Or Nursing Management industry. This means that ASTH’s stock grew similarly to HCA’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ASTHHCA
RSI
ODDS (%)
Bullish Trend 2 days ago
77%
Bearish Trend 2 days ago
64%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
80%
Bearish Trend 2 days ago
48%
Momentum
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
69%
MACD
ODDS (%)
Bullish Trend 2 days ago
82%
Bearish Trend 2 days ago
58%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
75%
Bearish Trend 2 days ago
58%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
79%
Bullish Trend 2 days ago
67%
Advances
ODDS (%)
Bullish Trend 10 days ago
80%
Bullish Trend 10 days ago
70%
Declines
ODDS (%)
Bearish Trend 7 days ago
73%
Bearish Trend 2 days ago
57%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
74%
Bearish Trend 2 days ago
49%
Aroon
ODDS (%)
Bearish Trend 2 days ago
85%
Bullish Trend 2 days ago
61%
View a ticker or compare two or three
Interact to see
Advertisement
ASTH
Daily Signal:
Gain/Loss:
HCA
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
WBIG23.640.15
+0.62%
WBI BullBear Yield 3000 ETF
SMDX23.030.14
+0.61%
Intech S&P Small-Mid Cap Diversified Alpha ETF
SPEU51.120.28
+0.55%
SPDR® Portfolio Europe ETF
DGRW90.050.48
+0.54%
WisdomTree US Quality Dividend Gr ETF
MUSI44.360.06
+0.14%
American Century Multisector Income ETF

ASTH and

Correlation & Price change

A.I.dvisor indicates that over the last year, ASTH has been loosely correlated with ACHC. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if ASTH jumps, then ACHC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ASTH
1D Price
Change %
ASTH100%
+0.88%
ACHC - ASTH
50%
Loosely correlated
-10.92%
DCGO - ASTH
40%
Loosely correlated
+12.46%
UHS - ASTH
32%
Poorly correlated
-3.57%
PNTG - ASTH
32%
Poorly correlated
-0.65%
HCA - ASTH
30%
Poorly correlated
-2.71%
More

HCA and

Correlation & Price change

A.I.dvisor indicates that over the last year, HCA has been closely correlated with UHS. These tickers have moved in lockstep 81% of the time. This A.I.-generated data suggests there is a high statistical probability that if HCA jumps, then UHS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HCA
1D Price
Change %
HCA100%
-2.71%
UHS - HCA
81%
Closely correlated
-3.57%
THC - HCA
72%
Closely correlated
-1.63%
ENSG - HCA
54%
Loosely correlated
-1.19%
CON - HCA
52%
Loosely correlated
-4.87%
CYH - HCA
48%
Loosely correlated
-1.11%
More